MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study-Reference-Cited by-同舟云学术

MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study

Published:2023-10 Issue:10 Volume:5 Page:e611-e621
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Hughes Michael^ORCID,Di Donato Stefano^ORCID,Gjeloshi Klodian,Abignano Giuseppina^ORCID,Danzo Fiammetta^ORCID,Lettieri Giovanni^ORCID,De Lorenzis Enrico^ORCID,Bertham Dominic^ORCID,O'Connor Philip^ORCID,Kubassova Olga,Dehmeshki Jamshid,Del Galdo Francesco^ORCID

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference30 articles.

1. Systemic sclerosis;Denton;Lancet,2017

2. Evidence that systemic sclerosis is a vascular disease;Matucci-Cerinic;Arthritis Rheum,2013

3. Raynaud phenomenon and digital ulcers in systemic sclerosis;Hughes;Nat Rev Rheumatol,2020

4. Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort;Hughes;Rheumatology (Oxford),2022

5. Cardiovascular disease in systemic sclerosis—an emerging association?;Ngian;Arthritis Res Ther,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease;Seminars in Arthritis and Rheumatism;2024-10

2. Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI;Current Opinion in Rheumatology;2024-08-08

3. Systematic literature review to inform the Portuguese recommendations for the management of Raynaud’s phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases;ARP Rheumatology;2024-06-30

4. DAVIX: a vascular outcome measure in systemic sclerosis;The Lancet Rheumatology;2023-10